Reta GLP-3

Triple-agonist research peptide under active investigation. 99%+ HPLC-verified purity. 40mg lyophilised vial.

• 40mg lyophilised vial
• Third-party tested for purity and identity
• Certificate of Analysis available
• Stored and shipped in optimal conditions
• UK-based supplier with tracked delivery

What is Reta GLP-3?

Reta GLP-3 is the retatrutide reference peptide: a triple-agonist research compound under active investigation, supplied as a 40mg lyophilised vial for in-vitro and preclinical research use only. Every 40mg vial is HPLC-tested by an independent laboratory and released against a lot-specific Certificate of Analysis with mass-spectrometry identity confirmation. For laboratory research use only. Not for human or veterinary use.

Verification & trust

Every batch ships with the per-lot Certificate of Analysis from an independent third-party laboratory, not in-house QC. The current lot was tested by Janoshik Analytical (task #149067) and can be verified online with the key printed on the report.

Storage & stability

Lyophilised (unreconstituted): stable up to 24 months at 2-8°C refrigerated, or up to 36 months at -20°C frozen. Protect from light and moisture; keep the vial upright.

Reconstituted: store at 2-8°C and use within 28 days. Do not freeze reconstituted solution. Label the vial with the reconstitution date.

Dispatch & delivery

Discreet, plain packaging with no product labelling visible externally. Returns cannot be accepted once products leave the controlled environment; damaged deliveries are replaced free of charge when reported with photos within 48 hours.

External resources for researchers

• Janoshik test report #149067

Product name	Reta GLP-3
Synonyms	Retatrutide, LY3437943
Amount	40mg per vial
Purity	≥ 99% (HPLC)
Form	Lyophilised powder
Solubility	Bacteriostatic water
Storage	Lyophilised: 2-8C up to 24 months or -20C up to 36 months. Reconstituted: 2-8C, use within 28 days.